EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogen patterns in viral ARDS on V-V ECMO: a single-center experience

Jannis Krais, Matthias Lubnow, Alois Philipp, Maik Foltan, Florian Geismann, Christoph Fisser, Florian Hitzenbichler, Bernd Salzberger, Stilla Bauernfeind, Barbara Schmid, Dirk Lunz, Johannes Steinmann und 9 weitere

Infection · 2026-10 · 54 (5) · 2549-2562

DOI: 10.1007/s15010-026-02879-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection, online erschienen am 15.07.2026. Verfasst von Jannis Krais und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II/Cardiology and Pulmonology, University Hospital Regensburg, Regensburg, Germany. Jannis.Krais@dhzc-charite.de. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Respiratory Distress Syndrome, COVID-19, Influenza, Human. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Regensburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Viral acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure requiring veno-venous extracorporeal membrane oxygenation (V-V ECMO). Pulmonary bacterial superinfections, pulmonary aspergillosis, and viral infections or reactivations frequently occur, but data on their incidence, timing, and microbiological spectrum remain limited. We analyzed infectious complications in a large cohort of V-V ECMO-treated patients with viral ARDS.

Methods

We retrospectively evaluated all patients treated at University Hospital Regensburg (UKR) requiring V-V ECMO for COVID-19 (March 2020–May 2022) or influenza (May 2012–December 2022).

Results

We included 147 COVID-19 patients (median age 55.3 years; 77% male; SOFA score 9; V-V ECMO duration 23 days) and 72 influenza patients (median age 55.3 years; 53% male; SOFA score 13; V-V ECMO duration 16 days). COVID-19 patients showed higher cumulative incidences of pulmonary bacterial superinfection (61% vs 35%), aspergillosis (33% vs. 22%), CMV reactivation (18%vs. 4%) and HSV reactivation (49% vs. 26%), however incidence-density rates were comparable between groups with incidence rate ratios (IRR) of 1.10, 0.93, 1.36 and 1.12, respectively. First bacterial pulmonary infection occurred a median of 2 days after V-V ECMO initiation in COVID-19 and 1 day before initiation in influenza patients. Predominant bacterial pathogens were Klebsiella spp. (28%), Staphylococcus aureus (27%) and Escherichia coli (11%) in COVID-19, and Staphylococcus aureus (25%) and Streptococcus pneumoniae (25%) in influenza.

Conclusion

Patients with COVID-19 requiring V-V ECMO showed a distinct trajectory of infectious complications compared to Influenza, particularly bacterial, HSV, CMV, and fungal infections, highlighting their infectious burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationRespiratory Distress SyndromeCOVID-19Influenza, HumanHumansMaleMiddle AgedRetrospective StudiesFemaleSuperinfectionAgedIncidenceAdult

Stichwörter der Autor:innen

Acute respiratory distress syndrome (ARDS)COVID-19Extracorporeal membrane oxygenation (ECMO)InfluenzaPulmonary aspergillosisSuperinfection

Autor:innen und Institutionen

  • Department of Internal Medicine II/Cardiology and Pulmonology, University Hospital Regensburg, Regensburg, Germany. Jannis.Krais@dhzc-charite.de.
  • Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité (DHZC), Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany. Jannis.Krais@dhzc-charite.de.
  • Department of Internal Medicine II/Cardiology and Pulmonology, University Hospital Regensburg, Regensburg, Germany.
  • Department of Pulmonology and Conservative Intensive Care Medicine, Barmherzige Brueder Hospital Regensburg, Regensburg, Germany.
  • Department of Cardiothoracic Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Department of Pulmonology, Caritas Hospital St. Maria, Donaustauf, Germany.

Förderung

  • Universitätsklinikum Regensburg

Zitieren

APA

Krais, J., Lubnow, M., Philipp, A., Foltan, M., Geismann, F., Fisser, C., Hitzenbichler, F., Salzberger, B., Bauernfeind, S., Schmid, B., Lunz, D., Steinmann, J., Eissnert, C., Kieninger, M., Petermichl, W., Schneckenpointner, R., Dietl, A., Maier, L. S., Graf, B., …, & Wiest, C. (2026). Pathogen patterns in viral ARDS on V-V ECMO: a single-center experience. Infection, 54(5), 2549-2562. https://doi.org/10.1007/s15010-026-02879-8

Vancouver

Krais J, Lubnow M, Philipp A, Foltan M, Geismann F, Fisser C, et al. Pathogen patterns in viral ARDS on V-V ECMO: a single-center experience. Infection. 2026;54(5):2549-2562. doi:10.1007/s15010-026-02879-8

BibTeX
@article{Krais2026,
  author = {Krais, Jannis and Lubnow, Matthias and Philipp, Alois and Foltan, Maik and Geismann, Florian and Fisser, Christoph and Hitzenbichler, Florian and Salzberger, Bernd and Bauernfeind, Stilla and Schmid, Barbara and Lunz, Dirk and Steinmann, Johannes and Eissnert, Christoph and Kieninger, Martin and Petermichl, Walter and Schneckenpointner, Roland and Dietl, Alexander and Maier, Lars S and Graf, Bernhard and Müller, Thomas and Wiest, Clemens},
  title = {Pathogen patterns in viral ARDS on V-V ECMO: a single-center experience},
  journal = {Infection},
  year = {2026},
  volume = {54},
  number = {5},
  pages = {2549--2562},
  doi = {10.1007/s15010-026-02879-8}
}
Kostenlos starten →